Drug Reference

Didanosine

Nucleoside and nucleotide reverse transcriptase inhibitors

← All medicines · Nucleoside and nucleotide reverse transcriptase inhibitors

Fact box

Therapeutic class
Nucleoside and nucleotide reverse transcriptase inhibitors
Action class
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Mechanism
Nucleoside Reverse Transcriptase Inhibitors
Chemical class
Nucleoside Analog
Habit forming
No

Available as

10 MG/ML · Oral Solution125 MG · Oral Capsule250 MG · Oral Capsule200 MG · Oral Capsule400 MG · Oral Capsule1 MG/ML · Oral Solution1.67 MG/ML · Oral Solution2.5 MG/ML · Oral Solution

No structured FDA label was available. Use the authoritative links below.

Current FDA labels (DailyMed)

8 marketed products on record (RxNorm)

Authoritative sources

Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.